Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kala Pharmaceuticals stock

Learn how to easily invest in Kala Pharmaceuticals stock.

Kala Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Kala Pharmaceuticals shares (KALA) are listed on the NASDAQ and all prices are listed in US Dollars. Kala Pharmaceuticals employs 188 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Kala Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KALA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Kala Pharmaceuticals stock price (NASDAQ: KALA)

Use our graph to track the performance of KALA stocks over time.

Kala Pharmaceuticals shares at a glance

Information last updated 2022-01-10.
Latest market close$1.04
52-week range$1.01 - $9.97
50-day moving average $1.67
200-day moving average $3.85
Wall St. target price$6.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.03

Buy Kala Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kala Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kala Pharmaceuticals price performance over time

Historical closes compared with the close of $1.04 from 2022-01-14

1 week (2022-01-10) -1.89%
1 month (2021-12-17) -25.71%
3 months (2021-10-15) -52.94%
6 months (2021-07-16) -72.63%
1 year (2021-01-15) -86.11%
2 years (2020-01-17) -84.05%
3 years (2019-01-17) 5.78
5 years (2017-01-13) N/A

Kala Pharmaceuticals financials

Revenue TTM $11.6 million
Gross profit TTM $4.2 million
Return on assets TTM -33.25%
Return on equity TTM -150.63%
Profit margin 0%
Book value $0.94
Market capitalisation $69.4 million

TTM: trailing 12 months

Kala Pharmaceuticals share dividends

We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months.

Kala Pharmaceuticals share price volatility

Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $1.01 up to $9.969. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kala Pharmaceuticals's is 0.2142. This would suggest that Kala Pharmaceuticals's shares are less volatile than average (for this exchange).

Kala Pharmaceuticals overview

Kala Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development programs comprise KPI-285/KPI-286, a receptor tyrosine kinase inhibitor program for the treatment of various retinal diseases; SEGRM program, a novel class of compounds designed to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway; and surface targeted steroid program (KPI-333), a new chemical entity as a topical steroid that targets the ocular surface. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009.

Frequently asked questions

What percentage of Kala Pharmaceuticals is owned by insiders or institutions?
Currently 0.992% of Kala Pharmaceuticals shares are held by insiders and 51.199% by institutions.
How many people work for Kala Pharmaceuticals?
Latest data suggests 188 work at Kala Pharmaceuticals.
When does the fiscal year end for Kala Pharmaceuticals?
Kala Pharmaceuticals's fiscal year ends in December.
Where is Kala Pharmaceuticals based?
Kala Pharmaceuticals's address is: 490 Arsenal Way, Watertown, MA, United States, 02472
What is Kala Pharmaceuticals's ISIN number?
Kala Pharmaceuticals's international securities identification number is: US4831191030
What is Kala Pharmaceuticals's CUSIP number?
Kala Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 483119103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site